NEUROONE MEDICAL TECHNOLOGIES Corp

Report Publication Announcement • Dec 11, 2025

News Details

Corporate | 11 December 2025 22:04

NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time

NeuroOne Medical Technologies / Key word(s): Financial

NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time

11.12.2025 / 22:04 CET/CEST

The issuer is solely responsible for the content of this announcement.

---

EDEN PRAIRIE, MINN. – December 11, 2025 ( NEWMEDIAWIRE ) – NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal fourth quarter and year ended September 30, 2025, before market open on December 17, 2025.

Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Wednesday, December 17, 2025, to discuss the Company’s fourth quarter and full fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

**Fiscal Fourth Quarter 2025 Earnings Conference Call

**Date: Wednesday, December 17, 2025

Time: 8:30 a.m. Eastern time

U.S. Dial-In (Toll Free): 888-506-0062

International Dial-In: 973-528-0011

Participant Access Code: 924910

Webcast: NMTC FY Q4 2025 Earnings Call Webcast

Please join at least five minutes before the start of the call to ensure timely participation

A playback of the call will be available through Wednesday, December 31, 2025. To listen to the replay, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 53302. A webcast replay will also be available using the webcast link above through Wednesday, December 31, 2025.

About NeuroOne

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com .

**IR Contact

**MZ Group – MZ North America

NMTC@mzgroup.us

View the original release on www.newmediawire.com

News Source: NeuroOne Medical Technologies

---

11.12.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group .

The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

---

Language:	English
Company:	NeuroOne Medical Technologies
	United States
ISIN:	US64130M2098
EQS News ID:	2244470

End of News	EQS News Service

---

2244470  11.12.2025 CET/CEST